{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T13:45:59Z","timestamp":1773495959250,"version":"3.50.1"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,14]]},"DOI":"10.7759\/cureus.105215","type":"journal-article","created":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T12:17:43Z","timestamp":1773490663000},"source":"Crossref","is-referenced-by-count":0,"title":["Management of Hypertension in Patients Undergoing Peritoneal Dialysis: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Ariv A","family":"Ramlal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anum","family":"Naimat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Ramakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazin","family":"Pattathil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarab","family":"Shahbaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumna","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mounica","family":"Bodige","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zakia","family":"Irum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinay","family":"Dontul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anisa","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Jaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1159\/000521861","article-title":"Epidemiology of hypertension among patients on peritoneal dialysis using standardized office and ambulatory blood pressure recordings","volume":"53","author":"Vareta G","year":"2022","unstructured":"Vareta G, Georgianos PI, Vaios V, et al.. Epidemiology of hypertension among patients on peritoneal dialysis using standardized office and ambulatory blood pressure recordings. Am J Nephrol. 2022, 53:139-147. 10.1159\/000521861","journal-title":"Am J Nephrol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-025-02719-3","article-title":"Association between blood pressure and cardiovascular events and mortality in patients on peritoneal dialysis: a systematic review and meta-analysis of observational studies","volume":"29","author":"Bezerra R","year":"2025","unstructured":"Bezerra R, Teles F, Nadruz W, et al.. Association between blood pressure and cardiovascular events and mortality in patients on peritoneal dialysis: a systematic review and meta-analysis of observational studies. Clin Exp Nephrol. 2025, 29:1840-1849. 10.1007\/s10157-025-02719-3","journal-title":"Clin Exp Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jash.2011.02.004","article-title":"Hypertension in peritoneal dialysis patients: epidemiology, pathogenesis, and treatment","volume":"5","author":"Ortega LM","year":"2011","unstructured":"Ortega LM, Materson BJ. Hypertension in peritoneal dialysis patients: epidemiology, pathogenesis, and treatment. J Am Soc Hypertens. 2011, 5:128-136. 10.1016\/j.jash.2011.02.004","journal-title":"J Am Soc Hypertens"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-023-00240-x","article-title":"Diagnosis and treatment of hypertension in dialysis patients: a systematic review","volume":"29","author":"Kim IS","year":"2023","unstructured":"Kim IS, Kim S, Yoo TH, Kim JK. Diagnosis and treatment of hypertension in dialysis patients: a systematic review. Clin Hypertens. 2023, 29:24. 10.1186\/s40885-023-00240-x","journal-title":"Clin Hypertens"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13443","article-title":"Clinic and home blood pressure monitoring for the detection of ambulatory hypertension among patients on peritoneal dialysis","volume":"74","author":"Vaios V","year":"2019","unstructured":"Vaios V, Georgianos PI, Vareta G, et al.. Clinic and home blood pressure monitoring for the detection of ambulatory hypertension among patients on peritoneal dialysis. Hypertension. 2019, 74:998-1004. 10.1161\/HYPERTENSIONAHA.119.13443","journal-title":"Hypertension"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney\u00a0disease","volume":"99","year":"2021","unstructured":"KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney\u00a0disease. Kidney Int. 2021, 99.S1-S87. 10.1016\/j.kint.2020.11.003","journal-title":"Kidney Int"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.07480618","article-title":"Assessment and management of hypertension among patients on peritoneal dialysis","volume":"14","author":"Vaios V","year":"2019","unstructured":"Vaios V, Georgianos PI, Liakopoulos V, Agarwal R. Assessment and management of hypertension among patients on peritoneal dialysis. Clin J Am Soc Nephrol. 2019, 14:297-305. 10.2215\/CJN.07480618","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-55561-5","article-title":"Effectiveness of renin-angiotensin-aldosterone system blockade on residual kidney function and peritoneal membrane function in peritoneal dialysis patients: a network meta-analysis","volume":"9","author":"Phatthanasobhon S","year":"2019","unstructured":"Phatthanasobhon S, Nochaiwong S, Thavorn K, et al.. Effectiveness of renin-angiotensin-aldosterone system blockade on residual kidney function and peritoneal membrane function in peritoneal dialysis patients: a network meta-analysis. Sci Rep. 2019, 9:19582. 10.1038\/s41598-019-55561-5","journal-title":"Sci Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2022.2148535","article-title":"Impact of fluid overload on blood pressure variability in patients on peritoneal dialysis","volume":"44","author":"Jin Y","year":"2022","unstructured":"Jin Y, Huang X, Zhang C, Xie J, Ren H. Impact of fluid overload on blood pressure variability in patients on peritoneal dialysis. Ren Fail. 2022, 44:2066-2072. 10.1080\/0886022X.2022.2148535","journal-title":"Ren Fail"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2014.00008","article-title":"The effect of fluid overload on clinical outcome in southern Chinese patients undergoing continuous ambulatory peritoneal dialysis","volume":"35","author":"Guo Q","year":"2015","unstructured":"Guo Q, Lin J, Li J, Yi C, Mao H, Yang X, Yu X. The effect of fluid overload on clinical outcome in southern Chinese patients undergoing continuous ambulatory peritoneal dialysis. Perit Dial Int. 2015, 35:691-702. 10.3747\/pdi.2014.00008","journal-title":"Perit Dial Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/20543581221150590","article-title":"Five things to know about volume overload in peritoneal dialysis","volume":"10","author":"Zheng S","year":"2023","unstructured":"Zheng S, Auguste BL. Five things to know about volume overload in peritoneal dialysis. Can J Kidney Health Dis. 2023, 10:20543581221150590. 10.1177\/20543581221150590","journal-title":"Can J Kidney Health Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13427","article-title":"The importance of residual kidney function in haemodialysis patients","volume":"23","author":"Kong J","year":"2018","unstructured":"Kong J, Davies M, Mount P. The importance of residual kidney function in haemodialysis patients. Nephrology (Carlton). 2018, 23:1073-1080. 10.1111\/nep.13427","journal-title":"Nephrology (Carlton)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/912595","article-title":"Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis","volume":"2012","author":"Baroni G","year":"2012","unstructured":"Baroni G, Schuinski A, de Moraes TP, Meyer F, Pecoits-Filho R. Inflammation and the peritoneal membrane: causes and impact on structure and function during peritoneal dialysis. Mediators Inflamm. 2012, 2012:912595. 10.1155\/2012\/912595","journal-title":"Mediators Inflamm"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000368972","article-title":"Ultrafiltration failure in peritoneal dialysis: a pathophysiologic approach","volume":"39","author":"Teitelbaum I","year":"2015","unstructured":"Teitelbaum I. Ultrafiltration failure in peritoneal dialysis: a pathophysiologic approach. Blood Purif. 2015, 39:70-73. 10.1159\/000368972","journal-title":"Blood Purif"},{"key":"ref15","article-title":"Physiology, renin angiotensin system","author":"Kaur J","year":"2026","unstructured":"Kaur J, Rout P. Physiology, renin angiotensin system. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2026."},{"key":"ref16","article-title":"The renin-angiotensin-aldosterone system in dialysis patients","author":"Morishita Y","year":"2012","unstructured":"Morishita Y, Kusano E. The renin-angiotensin-aldosterone system in dialysis patients. In: Novel Insights on Chronic Kidney Disease, Acute Kidney Injury and Polycystic Kidney Disease. Vijayakumar S (ed): IntechOpen, London; 2012."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18081682","article-title":"Sympathetic overactivity in chronic kidney disease: consequences and mechanisms","volume":"18","author":"Kaur J","year":"2017","unstructured":"Kaur J, Young BE, Fadel PJ. Sympathetic overactivity in chronic kidney disease: consequences and mechanisms. Int J Mol Sci. 2017, 18:1682. 10.3390\/ijms18081682","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2286328","article-title":"Influencing factors for residual kidney function in incident peritoneal dialysis patients: a systematic review and meta-analysis","volume":"45","author":"Zhou D","year":"2023","unstructured":"Zhou D, Lei H, Wu S, et al.. Influencing factors for residual kidney function in incident peritoneal dialysis patients: a systematic review and meta-analysis. Ren Fail. 2023, 45:2286328. 10.1080\/0886022X.2023.2286328","journal-title":"Ren Fail"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2016.10.007","article-title":"Inflammation and peritoneal dialysis","volume":"37","author":"Li PK","year":"2017","unstructured":"Li PK, Ng JK, Mcintyre CW. Inflammation and peritoneal dialysis. Semin Nephrol. 2017, 37:54-65. 10.1016\/j.semnephrol.2016.10.007","journal-title":"Semin Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000073","article-title":"Endothelial dysfunction is associated with major adverse cardiovascular events in peritoneal dialysis patients","volume":"93","author":"Lee MJ","year":"2014","unstructured":"Lee MJ, Han SH, Lee JE, et al.. Endothelial dysfunction is associated with major adverse cardiovascular events in peritoneal dialysis patients. Medicine (Baltimore). 2014, 93:e73. 10.1097\/MD.0000000000000073","journal-title":"Medicine (Baltimore)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1098725","article-title":"Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets","volume":"13","author":"Zhang Z","year":"2023","unstructured":"Zhang Z, Zhao L, Zhou X, Meng X, Zhou X. Role of inflammation, immunity, and oxidative stress in hypertension: new insights and potential therapeutic targets. Front Immunol. 2023, 13:1098725. 10.3389\/fimmu.2022.1098725","journal-title":"Front Immunol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.6.1536","article-title":"Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study","volume":"14","author":"Cocchi R","year":"1999","unstructured":"Cocchi R, Degli Esposti E, Fabbri A, et al.. Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrol Dial Transplant. 1999, 14:1536-1540. 10.1093\/ndt\/14.6.1536","journal-title":"Nephrol Dial Transplant"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/17.9.1661","article-title":"Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients","volume":"17","author":"Koc M","year":"2002","unstructured":"Koc M, Toprak A, Tezcan H, Bihorac A, Akoglu E, Ozener IC. Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients. Nephrol Dial Transplant. 2002, 17:1661-1666. 10.1093\/ndt\/17.9.1661","journal-title":"Nephrol Dial Transplant"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2011.11.015","article-title":"United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease & end-stage renal disease in the United States","volume":"59","author":"Collins AJ","year":"2012","unstructured":"Collins AJ, Foley RN, Chavers B, et al.. United States Renal Data System 2011 Annual Data Report: atlas of chronic kidney disease & end-stage renal disease in the United States. Am J Kidney Dis. 2012, 59:A7, e1-420. 10.1053\/j.ajkd.2011.11.015","journal-title":"Am J Kidney Dis"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/14.10.2438","article-title":"Dialysis in the Netherlands: the clinical condition of new patients put into a European perspective. NECOSAD Study Group. Netherlands Cooperative Study on the Adequacy of Dialysis phase 1","volume":"14","author":"Jager KJ","year":"1999","unstructured":"Jager KJ, Merkus MP, Boeschoten EW, Dekker FW, Stevens P, Krediet RT. Dialysis in the Netherlands: the clinical condition of new patients put into a European perspective. NECOSAD Study Group. Netherlands Cooperative Study on the Adequacy of Dialysis phase 1. Nephrol Dial Transplant. 1999, 14:2438-2444. 10.1093\/ndt\/14.10.2438","journal-title":"Nephrol Dial Transplant"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh856","article-title":"The association between BP and mortality in patients on chronic peritoneal dialysis","volume":"20","author":"Goldfarb-Rumyantzev AS","year":"2005","unstructured":"Goldfarb-Rumyantzev AS, Baird BC, Leypoldt JK, Cheung AK. The association between BP and mortality in patients on chronic peritoneal dialysis. Nephrol Dial Transplant. 2005, 20:1693-1701. 10.1093\/ndt\/gfh856","journal-title":"Nephrol Dial Transplant"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1159\/000087194","article-title":"Volume status and blood pressure in continuous ambulatory peritoneal dialysis patients","volume":"23","author":"Wang X","year":"2005","unstructured":"Wang X, Axelsson J, Lindholm B, Wang T. Volume status and blood pressure in continuous ambulatory peritoneal dialysis patients. Blood Purif. 2005, 23:373-378. 10.1159\/000087194","journal-title":"Blood Purif"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-021-01559-3","article-title":"Commentary on the KDIGO 2021 clinical practice guideline for the management of blood pressure in CKD","volume":"23","author":"Mann JF","year":"2021","unstructured":"Mann JF, Chang TI, Cushman WC, et al.. Commentary on the KDIGO 2021 clinical practice guideline for the management of blood pressure in CKD. Curr Cardiol Rep. 2021, 23:132. 10.1007\/s11886-021-01559-3","journal-title":"Curr Cardiol Rep"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2020.02.086","article-title":"Hypertension Canada's 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children","volume":"36","author":"Rabi DM","year":"2020","unstructured":"Rabi DM, McBrien KA, Sapir-Pichhadze R, et al.. Hypertension Canada's 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children. Can J Cardiol. 2020, 36:596-624. 10.1016\/j.cjca.2020.02.086","journal-title":"Can J Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.08.030","article-title":"Blood pressure measurement: a KDOQI perspective","volume":"75","author":"Drawz PE","year":"2020","unstructured":"Drawz PE, Beddhu S, Kramer HJ, Rakotz M, Rocco MV, Whelton PK. Blood pressure measurement: a KDOQI perspective. Am J Kidney Dis. 2020, 75:426-434. 10.1053\/j.ajkd.2019.08.030","journal-title":"Am J Kidney Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2019.01.007","article-title":"KDOQI US commentary on the 2017 ACC\/AHA hypertension guideline","volume":"73","author":"Kramer HJ","year":"2019","unstructured":"Kramer HJ, Townsend RR, Griffin K, et al.. KDOQI US commentary on the 2017 ACC\/AHA hypertension guideline. Am J Kidney Dis. 2019, 73:437-458. 10.1053\/j.ajkd.2019.01.007","journal-title":"Am J Kidney Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-2-200307150-00010","article-title":"Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis: a randomized, controlled study","volume":"139","author":"Li PK","year":"2003","unstructured":"Li PK, Chow KM, Wong TY, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis: a randomized, controlled study. Ann Intern Med. 2003, 139:105-112. 10.7326\/0003-4819-139-2-200307150-00010","journal-title":"Ann Intern Med"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2004.01.019","article-title":"Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD","volume":"43","author":"Suzuki H","year":"2004","unstructured":"Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H. Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis. 2004, 43:1056-1064. 10.1053\/j.ajkd.2004.01.019","journal-title":"Am J Kidney Dis"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-017-0616-4","article-title":"Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study","volume":"18","author":"Shen JI","year":"2017","unstructured":"Shen JI, Saxena AB, Vangala S, Dhaliwal SK, Winkelmayer WC. Renin-angiotensin system blockers and residual kidney function loss in patients initiating peritoneal dialysis: an observational cohort study. BMC Nephrol. 2017, 18:196. 10.1186\/s12882-017-0616-4","journal-title":"BMC Nephrol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2009.00088","article-title":"Treatment with angiotensin II inhibitors and residual renal function in peritoneal dialysis patients","volume":"31","author":"Kolesnyk I","year":"2011","unstructured":"Kolesnyk I, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT. Treatment with angiotensin II inhibitors and residual renal function in peritoneal dialysis patients. Perit Dial Int. 2011, 31:53-59. 10.3747\/pdi.2009.00088","journal-title":"Perit Dial Int"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.001918","article-title":"Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies","volume":"4","author":"Hung SC","year":"2015","unstructured":"Hung SC, Lai YS, Kuo KL, Tarng DC. Volume overload and adverse outcomes in chronic kidney disease: clinical observational and animal studies. J Am Heart Assoc. 2015, 4:10.1161\/JAHA.115.001918","journal-title":"J Am Heart Assoc"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.191_2.x","article-title":"A decline in residual glomerular filtration during the use of icodextrin may be due to underhydration","volume":"67","author":"Konings CJ","year":"2005","unstructured":"Konings CJ, Kooman JP, Gladziwa U, van der Sande FM, Leunissen KM. A decline in residual glomerular filtration during the use of icodextrin may be due to underhydration. Kidney Int. 2005, 67:1190-1191. 10.1111\/j.1523-1755.2005.191_2.x","journal-title":"Kidney Int"},{"key":"ref38","article-title":"The impact of sub-clinical over-hydration on left ventricular mass in peritoneal dialysis patients","volume":"8","author":"Hassan K","year":"2015","unstructured":"Hassan K, Hassan D, Shturman A, Rubinchik I, Fadi H, Shadi H, Atar S. The impact of sub-clinical over-hydration on left ventricular mass in peritoneal dialysis patients. Int J Clin Exp Med. 2015, 8:5890-5896.","journal-title":"Int J Clin Exp Med"},{"key":"ref39","article-title":"Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis","volume":"22","author":"Konings CJ","year":"2002","unstructured":"Konings CJ, Kooman JP, Schonck M, et al.. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int. 2002, 22:477-487.","journal-title":"Perit Dial Int"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2002.00505.x","article-title":"Predictors of the rate of decline of residual renal function in incident dialysis patients","volume":"62","author":"Jansen MA","year":"2002","unstructured":"Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int. 2002, 62:1046-1053. 10.1046\/j.1523-1755.2002.00505.x","journal-title":"Kidney Int"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv013","article-title":"Baseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)\u2020","volume":"30","author":"Ronco C","year":"2015","unstructured":"Ronco C, Verger C, Crepaldi C, et al.. Baseline hydration status in incident peritoneal dialysis patients: the initiative of patient outcomes in dialysis (IPOD-PD study)\u2020. Nephrol Dial Transplant. 2015, 30:849-858. 10.1093\/ndt\/gfv013","journal-title":"Nephrol Dial Transplant"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.11590918","article-title":"Evolution over time of volume status and PD-related practice patterns in an incident peritoneal dialysis cohort","volume":"14","author":"Van Biesen W","year":"2019","unstructured":"Van Biesen W, Verger C, Heaf J, et al.. Evolution over time of volume status and PD-related practice patterns in an incident peritoneal dialysis cohort. Clin J Am Soc Nephrol. 2019, 14:882-893. 10.2215\/CJN.11590918","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.10.007","article-title":"US Renal Data System 2010 Annual Data Report","volume":"57","author":"Collins AJ","year":"2011","unstructured":"Collins AJ, Foley RN, Herzog C, et al.. US Renal Data System 2010 Annual Data Report. Am J Kidney Dis. 2011, 57:A8. 10.1053\/j.ajkd.2010.10.007","journal-title":"Am J Kidney Dis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.5414\/cnp69193","article-title":"Patient and technique survival of diabetics on peritoneal dialysis: one-center's experience and review of the literature","volume":"69","author":"Fang W","year":"2008","unstructured":"Fang W, Yang X, Kothari J, et al.. Patient and technique survival of diabetics on peritoneal dialysis: one-center's experience and review of the literature. Clin Nephrol. 2008, 69:193-200. 10.5414\/cnp69193","journal-title":"Clin Nephrol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfh772","article-title":"Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre","volume":"20","author":"Chung SH","year":"2005","unstructured":"Chung SH, Heimb\u00fcrger O, Lindholm B, Lee HB. Peritoneal dialysis patient survival: a comparison between a Swedish and a Korean centre. Nephrol Dial Transplant. 2005, 20:1207-1213. 10.1093\/ndt\/gfh772","journal-title":"Nephrol Dial Transplant"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08921010","article-title":"Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus","volume":"6","author":"Duong U","year":"2011","unstructured":"Duong U, Mehrotra R, Molnar MZ, Noori N, Kovesdy CP, Nissenson AR, Kalantar-Zadeh K. Glycemic control and survival in peritoneal dialysis patients with diabetes mellitus. Clin J Am Soc Nephrol. 2011, 6:1041-1048. 10.2215\/CJN.08921010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0553","article-title":"Association between glycemia and mortality in diabetic individuals on renal replacement therapy in the U.K.","volume":"37","author":"Adler A","year":"2014","unstructured":"Adler A, Casula A, Steenkamp R, et al.. Association between glycemia and mortality in diabetic individuals on renal replacement therapy in the U.K.. Diabetes Care. 2014, 37:1304-1311. 10.2337\/dc13-0553","journal-title":"Diabetes Care"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136085","article-title":"Glycemic control and mortality in diabetic patients undergoing dialysis focusing on the effects of age and dialysis type: a prospective cohort study in Korea","volume":"10","author":"Park JI","year":"2015","unstructured":"Park JI, Bae E, Kim YL, et al.. Glycemic control and mortality in diabetic patients undergoing dialysis focusing on the effects of age and dialysis type: a prospective cohort study in Korea. PLoS One. 2015, 10:e0136085. 10.1371\/journal.pone.0136085","journal-title":"PLoS One"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2007.01.018","article-title":"New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis","volume":"49","author":"Szeto CC","year":"2007","unstructured":"Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK. New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis. Am J Kidney Dis. 2007, 49:524-532. 10.1053\/j.ajkd.2007.01.018","journal-title":"Am J Kidney Dis"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V7102169","article-title":"Early death in dialysis patients: risk factors and impact on incidence and mortality rates","volume":"7","author":"Soucie JM","year":"1996","unstructured":"Soucie JM, McClellan WM. Early death in dialysis patients: risk factors and impact on incidence and mortality rates. J Am Soc Nephrol. 1996, 7:2169-2175. 10.1681\/ASN.V7102169","journal-title":"J Am Soc Nephrol"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.132","article-title":"Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors","volume":"47","author":"Harnett JD","year":"1995","unstructured":"Harnett JD, Foley RN, Kent GM, Barre PE, Murray D, Parfrey PS. Congestive heart failure in dialysis patients: prevalence, incidence, prognosis and risk factors. Kidney Int. 1995, 47:884-890. 10.1038\/ki.1995.132","journal-title":"Kidney Int"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000070071.57901.b3","article-title":"Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?","volume":"14","author":"Wang AY","year":"2003","unstructured":"Wang AY, Woo J, Lam CW, et al.. Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients?. J Am Soc Nephrol. 2003, 14:1871-1879. 10.1097\/01.asn.0000070071.57901.b3","journal-title":"J Am Soc Nephrol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2001.060002767.x","article-title":"Effect of fluid and sodium removal on mortality in peritoneal dialysis patients","volume":"60","author":"Ate\u015f K","year":"2001","unstructured":"Ate\u015f K, Nergizo\u011flu G, Keven K, et al.. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int. 2001, 60:767-776. 10.1046\/j.1523-1755.2001.060002767.x","journal-title":"Kidney Int"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.krcp.2015.12.007","article-title":"Metabolic syndrome and obesity in peritoneal dialysis","volume":"35","author":"Lo WK","year":"2016","unstructured":"Lo WK. Metabolic syndrome and obesity in peritoneal dialysis. Kidney Res Clin Pract. 2016, 35:10-14. 10.1016\/j.krcp.2015.12.007","journal-title":"Kidney Res Clin Pract"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013060601","article-title":"Assessment and management of hypertension in patients on dialysis","volume":"25","author":"Agarwal R","year":"2014","unstructured":"Agarwal R, Flynn J, Pogue V, Rahman M, Reisin E, Weir MR. Assessment and management of hypertension in patients on dialysis. J Am Soc Nephrol. 2014, 25:1630-1646. 10.1681\/ASN.2013060601","journal-title":"J Am Soc Nephrol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2012.00027","article-title":"Blood pressure measurement in peritoneal dialysis: which method is best?","volume":"33","author":"O'Shaughnessy MM","year":"2013","unstructured":"O'Shaughnessy MM, Durcan M, Kinsella SM, Griffin MD, Reddan DN, Lappin DW. Blood pressure measurement in peritoneal dialysis: which method is best?. Perit Dial Int. 2013, 33:544-551. 10.3747\/pdi.2012.00027","journal-title":"Perit Dial Int"},{"key":"ref57","article-title":"Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens","volume":"21","author":"Wang MC","year":"2001","unstructured":"Wang MC, Tseng CC, Tsai WC, Huang JJ. Blood pressure and left ventricular hypertrophy in patients on different peritoneal dialysis regimens. Perit Dial Int. 2001, 21:36-42.","journal-title":"Perit Dial Int"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1159\/000337849","article-title":"Bioimpedance and brain natriuretic peptide in peritoneal dialysis patients","volume":"178","author":"Crepaldi C","year":"2012","unstructured":"Crepaldi C, Lamas EI, Martino FK, et al.. Bioimpedance and brain natriuretic peptide in peritoneal dialysis patients. Contrib Nephrol. 2012, 178:174-181. 10.1159\/000337849","journal-title":"Contrib Nephrol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1159\/000509115","article-title":"Assessment of hydration status in peritoneal dialysis patients: validity, prognostic value, strengths, and limitations of available techniques","volume":"51","author":"Alexandrou ME","year":"2020","unstructured":"Alexandrou ME, Balafa O, Sarafidis P. Assessment of hydration status in peritoneal dialysis patients: validity, prognostic value, strengths, and limitations of available techniques. Am J Nephrol. 2020, 51:589-612. 10.1159\/000509115","journal-title":"Am J Nephrol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1159\/000093670","article-title":"Residual renal function and volume control in peritoneal dialysis patients","volume":"104","author":"Cheng LT","year":"2006","unstructured":"Cheng LT, Chen W, Tang W, Wang T. Residual renal function and volume control in peritoneal dialysis patients. Nephron Clin Pract. 2006, 104:c47-c54. 10.1159\/000093670","journal-title":"Nephron Clin Pract"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.14744\/SEMB.2018.59219","article-title":"Does residual renal function have a beneficial effect on patient and technique survival in peritoneal dialysis patients?","volume":"52","author":"Ahbap E","year":"2018","unstructured":"Ahbap E, Sevin\u00e7 M. Does residual renal function have a beneficial effect on patient and technique survival in peritoneal dialysis patients?. Sisli Etfal Hastan Tip Bul. 2018, 52:184-189. 10.14744\/SEMB.2018.59219","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.07.031","article-title":"Low-sodium versus standard-sodium peritoneal dialysis solution in hypertensive patients: a randomized controlled trial","volume":"67","author":"Rutkowski B","year":"2016","unstructured":"Rutkowski B, Tam P, van der Sande FM, Vychytil A, Schwenger V, Himmele R, Gauly A. Low-sodium versus standard-sodium peritoneal dialysis solution in hypertensive patients: a randomized controlled trial. Am J Kidney Dis. 2016, 67:753-761. 10.1053\/j.ajkd.2015.07.031","journal-title":"Am J Kidney Dis"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1177\/08968608231222141","article-title":"Why should we use a low sodium dialysis solution for peritoneal dialysis?","volume":"44","author":"Nakayama M","year":"2024","unstructured":"Nakayama M. Why should we use a low sodium dialysis solution for peritoneal dialysis?. Perit Dial Int. 2024, 44:89-97. 10.1177\/08968608231222141","journal-title":"Perit Dial Int"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13231","article-title":"Abdominal aortic calcification score predicts the occurrence of coronary artery disease in middle-aged peritoneal dialysis patients","volume":"24","author":"Chen HC","year":"2019","unstructured":"Chen HC, Chou CY, Lin HJ, Huang CC, Chang CT. Abdominal aortic calcification score predicts the occurrence of coronary artery disease in middle-aged peritoneal dialysis patients. Nephrology (Carlton). 2019, 24:336-340. 10.1111\/nep.13231","journal-title":"Nephrology (Carlton)"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2023.2261786","article-title":"The association of left ventricular fraction shortening with cardiovascular events in peritoneal dialysis patients","volume":"45","author":"Dai L","year":"2023","unstructured":"Dai L, Yang Y, Liu L, et al.. The association of left ventricular fraction shortening with cardiovascular events in peritoneal dialysis patients. Ren Fail. 2023, 45:2261786. 10.1080\/0886022X.2023.2261786","journal-title":"Ren Fail"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-21226-y","article-title":"Bioimpedance-defined overhydration predicts survival in end stage kidney failure (ESKF): systematic review and subgroup meta-analysis","volume":"8","author":"Tabinor M","year":"2018","unstructured":"Tabinor M, Elphick E, Dudson M, Kwok CS, Lambie M, Davies SJ. Bioimpedance-defined overhydration predicts survival in end stage kidney failure (ESKF): systematic review and subgroup meta-analysis. Sci Rep. 2018, 8:4441. 10.1038\/s41598-018-21226-y","journal-title":"Sci Rep"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn668","article-title":"The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status","volume":"24","author":"Davies S","year":"2009","unstructured":"Davies S, Carlsson O, Simonsen O, et al.. The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status. Nephrol Dial Transplant. 2009, 24:1609-1617. 10.1093\/ndt\/gfn668","journal-title":"Nephrol Dial Transplant"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1111\/j.0894-0959.2004.17327.x","article-title":"Hypertension in hemodialysis patients: dialysate composition and hemodialysis hypertension","volume":"17","author":"Flanigan M","year":"2004","unstructured":"Flanigan M. Hypertension in hemodialysis patients: dialysate composition and hemodialysis hypertension. Semin Dial. 2004, 17:279-283. 10.1111\/j.0894-0959.2004.17327.x","journal-title":"Semin Dial"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2010.00146","article-title":"The beneficial influence on the effectiveness of automated peritoneal dialysis of varying the dwell time (short\/long) and fill volume (small\/large): a randomized controlled trial","volume":"31","author":"Fischbach M","year":"2011","unstructured":"Fischbach M, Issad B, Dubois V, Taamma R. The beneficial influence on the effectiveness of automated peritoneal dialysis of varying the dwell time (short\/long) and fill volume (small\/large): a randomized controlled trial. Perit Dial Int. 2011, 31:450-458. 10.3747\/pdi.2010.00146","journal-title":"Perit Dial Int"},{"key":"ref70","unstructured":"Renal replacement therapy and conservative management. (2018). Accessed. March 10, 2026: https:\/\/www.nice.org.uk\/guidance\/ng107\/chapter\/recommendations."},{"key":"ref71","article-title":"Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass in patients on continuous ambulatory peritoneal dialysis","volume":"29","author":"Sav T","year":"2009","unstructured":"Sav T, Oymak O, Inanc MT, Dogan A, Tokgoz B, Utas C. Effects of twice-daily icodextrin administration on blood pressure and left ventricular mass in patients on continuous ambulatory peritoneal dialysis. Perit Dial Int. 2009, 29:443-449.","journal-title":"Perit Dial Int"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907355","article-title":"Projected effect of dietary salt reductions on future cardiovascular disease","volume":"362","author":"Bibbins-Domingo K","year":"2010","unstructured":"Bibbins-Domingo K, Chertow GM, Coxson PG, Moran A, Lightwood JM, Pletcher MJ, Goldman L. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010, 362:590-599. 10.1056\/NEJMoa0907355","journal-title":"N Engl J Med"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3906\/sag-1308-58","article-title":"The effect of dietary salt restriction on hypertension in peritoneal dialysis patients","volume":"44","author":"\u0130nal S","year":"2014","unstructured":"\u0130nal S, Erten Y, Tek N, Ulusal Okyay G, \u00d6ne\u00e7 K, Akbulut G, \u015eanlier N. The effect of dietary salt restriction on hypertension in peritoneal dialysis patients. Turk J Med Sci. 2014, 44:814-819. 10.3906\/sag-1308-58","journal-title":"Turk J Med Sci"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.nefro.2021.02.007","article-title":"Physical exercise and peritoneal dialysis: an area yet to be explored","volume":"42","author":"Maia Neves Menezes JI","year":"2021","unstructured":"Maia Neves Menezes JI, Lopes Pereira LA. Physical exercise and peritoneal dialysis: an area yet to be explored. Nefrologia (Engl Ed). 2021, 42:265-272. 10.1016\/j.nefro.2021.02.007","journal-title":"Nefrologia (Engl Ed)"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1007\/BF00735961","article-title":"ACE inhibitors and proteinuria","volume":"18","author":"Gansevoort RT","year":"1996","unstructured":"Gansevoort RT, de Zeeuw D, de Jong PE. ACE inhibitors and proteinuria. Pharm World Sci. 1996, 18:204-210. 10.1007\/BF00735961","journal-title":"Pharm World Sci"},{"key":"ref76","article-title":"Reduction of proteinuria by angiotensin converting enzyme inhibition","volume":"32","author":"Heeg JE","year":"1987","unstructured":"Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D. Reduction of proteinuria by angiotensin converting enzyme inhibition. Kidney Int. 1987, 32:78-83.","journal-title":"Kidney Int"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1002\/clc.4960151027","article-title":"ACE inhibitors and regression of left ventricular hypertrophy","volume":"15","author":"Gilbert BW","year":"1992","unstructured":"Gilbert BW. ACE inhibitors and regression of left ventricular hypertrophy. Clin Cardiol. 1992, 15:711-714. 10.1002\/clc.4960151027","journal-title":"Clin Cardiol"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2010.00258.x","article-title":"Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"30","author":"Raebel MA","year":"2012","unstructured":"Raebel MA. Hyperkalemia associated with use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. Cardiovasc Ther. 2012, 30:e156-e166. 10.1111\/j.1755-5922.2010.00258.x","journal-title":"Cardiovasc Ther"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009120.pub2","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients","volume":"2014","author":"Zhang L","year":"2014","unstructured":"Zhang L, Zeng X, Fu P, Wu HM. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients. Cochrane Database Syst Rev. 2014, 2014:CD009120. 10.1002\/14651858.CD009120.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1179\/acb.2004.007","article-title":"Calcium channel blockers in the prevention of end stage renal disease: a review","volume":"59","author":"Derwa A","year":"2004","unstructured":"Derwa A, Peeters P, Vanholder R. Calcium channel blockers in the prevention of end stage renal disease: a review. Acta Clin Belg. 2004, 59:44-56. 10.1179\/acb.2004.007","journal-title":"Acta Clin Belg"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/12.11.2244","article-title":"Preservation of renal function: the spectrum of effects by calcium-channel blockers","volume":"12","author":"Tarif N","year":"1997","unstructured":"Tarif N, Bakris GL. Preservation of renal function: the spectrum of effects by calcium-channel blockers. Nephrol Dial Transplant. 1997, 12:2244-2250. 10.1093\/ndt\/12.11.2244","journal-title":"Nephrol Dial Transplant"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3869","article-title":"Relationship between calcium channel blocker class and mortality in dialysis","volume":"24","author":"Wetmore JB","year":"2015","unstructured":"Wetmore JB, Mahnken JD, Phadnis MA, Ellerbeck EF, Shireman TI. Relationship between calcium channel blocker class and mortality in dialysis. Pharmacoepidemiol Drug Saf. 2015, 24:1249-1258. 10.1002\/pds.3869","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)90773-0","article-title":"Beta-blockers in heart failure: promising or proved?","volume":"23","author":"Doughty RN","year":"1994","unstructured":"Doughty RN, MacMahon S, Sharpe N. Beta-blockers in heart failure: promising or proved?. J Am Coll Cardiol. 1994, 23:814-821. 10.1016\/0735-1097(94)90773-0","journal-title":"J Am Coll Cardiol"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a015297","article-title":"Effects of beta-blocker therapy on mortality in patients with heart failure: a systematic overview of randomized controlled trials","volume":"18","author":"Doughty RN","year":"1997","unstructured":"Doughty RN, Rodgers A, Sharpe N, MacMahon S. Effects of beta-blocker therapy on mortality in patients with heart failure: a systematic overview of randomized controlled trials. Eur Heart J. 1997, 18:560-565. 10.1093\/oxfordjournals.eurheartj.a015297","journal-title":"Eur Heart J"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1177\/089686088100200410","article-title":"High-dose diuretics in continuous ambulatory peritoneal dialysis","volume":"2","author":"Searpioni L","year":"1981","unstructured":"Searpioni L, Ballocchi S, Bergonzi G, Fontana F, Poisetti P, Zanazzi MA. High-dose diuretics in continuous ambulatory peritoneal dialysis. Peritoneal Dial Int. 1981, 2:177-178. 10.1177\/089686088100200410","journal-title":"Peritoneal Dial Int"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpa.2003.09.003","article-title":"Should we use diuretics in acute renal failure?","volume":"18","author":"Schetz M","year":"2004","unstructured":"Schetz M. Should we use diuretics in acute renal failure?. Best Pract Res Clin Anaesthesiol. 2004, 18:75-89. 10.1016\/j.bpa.2003.09.003","journal-title":"Best Pract Res Clin Anaesthesiol"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2013.11.006","article-title":"The cardioprotective effects of mineralocorticoid receptor antagonists","volume":"142","author":"van den Berg TN","year":"2014","unstructured":"van den Berg TN, Rongen GA, Fr\u00f6hlich GM, Deinum J, Hausenloy DJ, Riksen NP. The cardioprotective effects of mineralocorticoid receptor antagonists. Pharmacol Ther. 2014, 142:72-87. 10.1016\/j.pharmthera.2013.11.006","journal-title":"Pharmacol Ther"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000003639","article-title":"Mineralocorticoid receptor antagonist treatment in patients with renal insufficiency and the associated risk of hyperkalemia and death","volume":"42","author":"Hedlund M\u00f8ller S","year":"2024","unstructured":"Hedlund M\u00f8ller S, Haagensen Kofod D, Schou M, Torp-Pedersen C, Gislason G, Carlson N, Lindhardt M. Mineralocorticoid receptor antagonist treatment in patients with renal insufficiency and the associated risk of hyperkalemia and death. J Hypertens. 2024, 42:564-571. 10.1097\/HJH.0000000000003639","journal-title":"J Hypertens"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2011.00268.x","article-title":"Pharmacological properties of the central antihypertensive agent, moxonidine","volume":"30","author":"Edwards LP","year":"2012","unstructured":"Edwards LP, Brown-Bryan TA, McLean L, Ernsberger P. Pharmacological properties of the central antihypertensive agent, moxonidine. Cardiovasc Ther. 2012, 30:199-208. 10.1111\/j.1755-5922.2011.00268.x","journal-title":"Cardiovasc Ther"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-199715011-00007","article-title":"The use of moxonidine in the treatment of hypertension","volume":"15","author":"Prichard BN","year":"1997","unstructured":"Prichard BN, Graham BR. The use of moxonidine in the treatment of hypertension. J Hypertens Suppl. 1997, 15:S47-S55. 10.1097\/00004872-199715011-00007","journal-title":"J Hypertens Suppl"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2005.00672.x","article-title":"Use of moxonidine in elderly patients with resistant hypertension","volume":"30","author":"Martin U","year":"2005","unstructured":"Martin U, Hill C, O' Mahony D. Use of moxonidine in elderly patients with resistant hypertension. J Clin Pharm Ther. 2005, 30:433-437. 10.1111\/j.1365-2710.2005.00672.x","journal-title":"J Clin Pharm Ther"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14455","article-title":"Current apparent treatment-resistant hypertension in patients undergoing peritoneal dialysis: a multi-center cross-sectional study","volume":"24","author":"Li D","year":"2022","unstructured":"Li D, Huo Z, Liu D, et al.. Current apparent treatment-resistant hypertension in patients undergoing peritoneal dialysis: a multi-center cross-sectional study. J Clin Hypertens (Greenwich). 2022, 24:493-501. 10.1111\/jch.14455","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2016010112","article-title":"The current state of peritoneal dialysis","volume":"27","author":"Mehrotra R","year":"2016","unstructured":"Mehrotra R, Devuyst O, Davies SJ, Johnson DW. The current state of peritoneal dialysis. J Am Soc Nephrol. 2016, 27:3238-3252. 10.1681\/ASN.2016010112","journal-title":"J Am Soc Nephrol"},{"key":"ref94","doi-asserted-by":"crossref","DOI":"10.1053\/ajkd.2001.22085","article-title":"Strict volume control normalizes hypertension in peritoneal dialysis patients","volume":"37","author":"G\u00fcnal AI","year":"2001","unstructured":"G\u00fcnal AI, Duman S, Ozkahya M, T\u00f6z H, As\u00e7i G, Ak\u00e7i\u00e7ek F, Bas\u00e7i A. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis. 2001, 37:588-593.","journal-title":"Am J Kidney Dis"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00887.x","article-title":"Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study","volume":"63","author":"Konings CJ","year":"2003","unstructured":"Konings CJ, Kooman JP, Schonck M, et al.. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int. 2003, 63:1556-1563. 10.1046\/j.1523-1755.2003.00887.x","journal-title":"Kidney Int"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000083904.12234.27","article-title":"Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial","volume":"14","author":"Davies SJ","year":"2003","unstructured":"Davies SJ, Woodrow G, Donovan K, et al.. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol. 2003, 14:2338-2344. 10.1097\/01.asn.0000083904.12234.27","journal-title":"J Am Soc Nephrol"},{"key":"ref97","doi-asserted-by":"crossref","DOI":"10.1177\/089686080902900409","article-title":"Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients","volume":"29","author":"Paniagua R","year":"2009","unstructured":"Paniagua R, Ventura MD, Avila-D\u00edaz M, et al.. Icodextrin improves metabolic and fluid management in high and high-average transport diabetic patients. Perit Dial Int. 2009, 29:422-432.","journal-title":"Perit Dial Int"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfn321","article-title":"Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis","volume":"23","author":"Fang W","year":"2008","unstructured":"Fang W, Oreopoulos DG, Bargman JM. Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis. Nephrol Dial Transplant. 2008, 23:3704-3710. 10.1093\/ndt\/gfn321","journal-title":"Nephrol Dial Transplant"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V12102158","article-title":"Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study","volume":"12","author":"Bargman JM","year":"2001","unstructured":"Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol. 2001, 12:2158-2162. 10.1681\/ASN.V12102158","journal-title":"J Am Soc Nephrol"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2016.10.006","article-title":"Fluid overload in peritoneal dialysis patients","volume":"37","author":"Kim YL","year":"2017","unstructured":"Kim YL, Biesen WV. Fluid overload in peritoneal dialysis patients. Semin Nephrol. 2017, 37:43-53. 10.1016\/j.semnephrol.2016.10.006","journal-title":"Semin Nephrol"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013030273","article-title":"Long-term effects of spironolactone in peritoneal dialysis patients","volume":"25","author":"Ito Y","year":"2014","unstructured":"Ito Y, Mizuno M, Suzuki Y, et al.. Long-term effects of spironolactone in peritoneal dialysis patients. J Am Soc Nephrol. 2014, 25:1094-1102. 10.1681\/ASN.2013030273","journal-title":"J Am Soc Nephrol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1111\/jch.12628","article-title":"Long-term effects of low-dose spironolactone on chronic dialysis patients: a randomized placebo-controlled study","volume":"18","author":"Lin C","year":"2016","unstructured":"Lin C, Zhang Q, Zhang H, Lin A. Long-term effects of low-dose spironolactone on chronic dialysis patients: a randomized placebo-controlled study. J Clin Hypertens (Greenwich). 2016, 18:121-128. 10.1111\/jch.12628","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e328351d08a","article-title":"Resistant hypertension and obstructive sleep apnea in the setting of kidney disease","volume":"30","author":"Abdel-Kader K","year":"2012","unstructured":"Abdel-Kader K, Dohar S, Shah N, et al.. Resistant hypertension and obstructive sleep apnea in the setting of kidney disease. J Hypertens. 2012, 30:960-966. 10.1097\/HJH.0b013e328351d08a","journal-title":"J Hypertens"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1111\/nep.12986","article-title":"Peritonitis as a risk factor for long-term cardiovascular mortality in peritoneal dialysis patients: the case of a friendly fire?","volume":"23","author":"Pecoits-Filho R","year":"2018","unstructured":"Pecoits-Filho R, Yabumoto FM, Campos LG, et al.. Peritonitis as a risk factor for long-term cardiovascular mortality in peritoneal dialysis patients: the case of a friendly fire?. Nephrology (Carlton). 2018, 23:253-258. 10.1111\/nep.12986","journal-title":"Nephrology (Carlton)"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.08.008","article-title":"Association of peritonitis with cardiovascular mortality over time in the peritoneal dialysis population: an Australia and New Zealand dialysis and transplant registry study","volume":"7","author":"Cheikh Hassan HI","year":"2022","unstructured":"Cheikh Hassan HI, Murali K, Lonergan M, Boudville N, Johnson D, Borlace M, Chen JH. Association of peritonitis with cardiovascular mortality over time in the peritoneal dialysis population: an Australia and New Zealand dialysis and transplant registry study. Kidney Int Rep. 2022, 7:2388-2396. 10.1016\/j.ekir.2022.08.008","journal-title":"Kidney Int Rep"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.4103\/1319-2442.284006","article-title":"Low serum albumin a predictor sign of the incidence of peritoneal dialysis-associated peritonitis? A quasi-systematic review","volume":"31","author":"Alharbi MA","year":"2020","unstructured":"Alharbi MA. Low serum albumin a predictor sign of the incidence of peritoneal dialysis-associated peritonitis? A quasi-systematic review. Saudi J Kidney Dis Transpl. 2020, 31:320-334. 10.4103\/1319-2442.284006","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112232","article-title":"The relation of clinic and ambulatory BP with the risk of cardiovascular events and all-cause mortality among patients on peritoneal dialysis","volume":"10","author":"Georgianos PI","year":"2021","unstructured":"Georgianos PI, Vaios V, Zebekakis PE, Liakopoulos V. The relation of clinic and ambulatory BP with the risk of cardiovascular events and all-cause mortality among patients on peritoneal dialysis. J Clin Med. 2021, 10:2232. 10.3390\/jcm10112232","journal-title":"J Clin Med"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.3747\/pdi.2017.00054","article-title":"Remote patient management in automated peritoneal dialysis: a promising new tool","volume":"38","author":"Drepper VJ","year":"2018","unstructured":"Drepper VJ, Martin PY, Chopard CS, Sloand JA. Remote patient management in automated peritoneal dialysis: a promising new tool. Perit Dial Int. 2018, 38:76-78. 10.3747\/pdi.2017.00054","journal-title":"Perit Dial Int"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab111","article-title":"The utility of remote patient management in peritoneal dialysis","volume":"14","author":"Yeter HH","year":"2021","unstructured":"Yeter HH, Manani SM, Ronco C. The utility of remote patient management in peritoneal dialysis. Clin Kidney J. 2021, 14:2483-2489. 10.1093\/ckj\/sfab111","journal-title":"Clin Kidney J"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.5414\/CN110497","article-title":"Application of a nurse-led multidisciplinary health problem assessment tool on patients undergoing peritoneal dialysis at home: a\u00a0cross-sectional study","volume":"96","author":"Luo Y","year":"2021","unstructured":"Luo Y, Huang Y, Cui M, Zhang J, Zhang Y. Application of a nurse-led multidisciplinary health problem assessment tool on patients undergoing peritoneal dialysis at home: a\u00a0cross-sectional study. Clin Nephrol. 2021, 96:317-327. 10.5414\/CN110497","journal-title":"Clin Nephrol"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijnsa.2022.100102","article-title":"Nurse-based educational interventions in patients with peritoneal dialysis: a systematic review and meta-analysis","volume":"4","author":"Nopsopon T","year":"2022","unstructured":"Nopsopon T, Kantagowit P, Chumsri C, et al.. Nurse-based educational interventions in patients with peritoneal dialysis: a systematic review and meta-analysis. Int J Nurs Stud Adv. 2022, 4:100102. 10.1016\/j.ijnsa.2022.100102","journal-title":"Int J Nurs Stud Adv"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1002\/ncp.11256","article-title":"Effect of multidisciplinary medical nutrition therapy on the nutrition status of patients receiving peritoneal dialysis: a randomized controlled trial","volume":"40","author":"Liang Y","year":"2025","unstructured":"Liang Y, Xu F, Guo L, Jiang W, Li J, Shu P. Effect of multidisciplinary medical nutrition therapy on the nutrition status of patients receiving peritoneal dialysis: a randomized controlled trial. Nutr Clin Pract. 2025, 40:106-116. 10.1002\/ncp.11256","journal-title":"Nutr Clin Pract"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.116.004007","article-title":"Effect of sodium-glucose cotransport-2 inhibitors on blood pressure in people with type 2 diabetes mellitus: a systematic review and meta-analysis of 43 randomized control trials with 22 528 patients","volume":"6","author":"Mazidi M","year":"2017","unstructured":"Mazidi M, Rezaie P, Gao HK, Kengne AP. Effect of sodium-glucose cotransport-2 inhibitors on blood pressure in people with type 2 diabetes mellitus: a systematic review and meta-analysis of 43 randomized control trials with 22 528 patients. J Am Heart Assoc. 2017, 6:10.1161\/JAHA.116.004007","journal-title":"J Am Heart Assoc"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1177\/20543581241293500","article-title":"Role of SGLT-2 inhibitors in ultrafiltration failure in peritoneal dialysis: a narrative review","volume":"11","author":"Riedl Khursigara M","year":"2024","unstructured":"Riedl Khursigara M, Liu P, Kaur R, Mavrakanas TA. Role of SGLT-2 inhibitors in ultrafiltration failure in peritoneal dialysis: a narrative review. Can J Kidney Health Dis. 2024, 11:20543581241293500. 10.1177\/20543581241293500","journal-title":"Can J Kidney Health Dis"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1186\/s41100-024-00523-5","article-title":"SGLT2 inhibitors in peritoneal dialysis: a promising frontier toward improved patient outcomes","volume":"10","author":"Stepanova N","year":"2024","unstructured":"Stepanova N. SGLT2 inhibitors in peritoneal dialysis: a promising frontier toward improved patient outcomes. Ren Replace Ther. 2024, 10:5. 10.1186\/s41100-024-00523-5","journal-title":"Ren Replace Ther"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-019-4859-4","article-title":"Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease","volume":"62","author":"Heerspink HJ","year":"2019","unstructured":"Heerspink HJ, Perco P, Mulder S, Leierer J, Hansen MK, Heinzel A, Mayer G. Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease. Diabetologia. 2019, 62:1154-1166. 10.1007\/s00125-019-4859-4","journal-title":"Diabetologia"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1159\/000521691","article-title":"Lung ultrasound as a tool to evaluate fluid accumulation in dialysis patients","volume":"47","author":"Alexandrou ME","year":"2022","unstructured":"Alexandrou ME, Theodorakopoulou MP, Sarafidis PA. Lung ultrasound as a tool to evaluate fluid accumulation in dialysis patients. Kidney Blood Press Res. 2022, 47:163-176. 10.1159\/000521691","journal-title":"Kidney Blood Press Res"},{"key":"ref118","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.5.1690","article-title":"\"Ultrasound comet-tail images\": a marker of pulmonary edema: a comparative study with wedge pressure and extravascular lung water","volume":"127","author":"Agricola E","year":"2005","unstructured":"Agricola E, Bove T, Oppizzi M, Marino G, Zangrillo A, Margonato A, Picano E. \"Ultrasound comet-tail images\": a marker of pulmonary edema: a comparative study with wedge pressure and extravascular lung water. Chest. 2005, 127:1690-1695. 10.1378\/chest.127.5.1690","journal-title":"Chest"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1111\/sdi.12559","article-title":"Lung ultrasound in the management of fluid volume in dialysis patients: potential usefulness","volume":"30","author":"Zoccali C","year":"2017","unstructured":"Zoccali C. Lung ultrasound in the management of fluid volume in dialysis patients: potential usefulness. Semin Dial. 2017, 30:6-9. 10.1111\/sdi.12559","journal-title":"Semin Dial"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2017.10.009","article-title":"Use of lung ultrasound for the assessment of volume status in CKD","volume":"71","author":"Covic A","year":"2018","unstructured":"Covic A, Siriopol D, Voroneanu L. Use of lung ultrasound for the assessment of volume status in CKD. Am J Kidney Dis. 2018, 71:412-422. 10.1053\/j.ajkd.2017.10.009","journal-title":"Am J Kidney Dis"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.2196\/53355","article-title":"Efficacy of a web-based home blood pressure monitoring program in improving predialysis blood pressure control among patients undergoing hemodialysis: randomized controlled trial","volume":"12","author":"Chen T","year":"2024","unstructured":"Chen T, Zhao W, Pei Q, et al.. Efficacy of a web-based home blood pressure monitoring program in improving predialysis blood pressure control among patients undergoing hemodialysis: randomized controlled trial. JMIR Mhealth Uhealth. 2024, 12:e53355. 10.2196\/53355","journal-title":"JMIR Mhealth Uhealth"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.06.014","article-title":"Treating home versus predialysis blood pressure among in-center hemodialysis patients: a pilot randomized trial","volume":"77","author":"Bansal N","year":"2021","unstructured":"Bansal N, Glidden DV, Mehrotra R, et al.. Treating home versus predialysis blood pressure among in-center hemodialysis patients: a pilot randomized trial. Am J Kidney Dis. 2021, 77:12-22. 10.1053\/j.ajkd.2020.06.014","journal-title":"Am J Kidney Dis"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1035","article-title":"Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial","volume":"346","author":"Henderson C","year":"2013","unstructured":"Henderson C, Knapp M, Fern\u00e1ndez JL, et al.. Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial. BMJ. 2013, 346:f1035. 10.1136\/bmj.f1035","journal-title":"BMJ"},{"key":"ref124","doi-asserted-by":"publisher","DOI":"10.3390\/nu13072282","article-title":"Biological effects of XyloCore, a glucose sparing PD solution, on mesothelial cells: focus on mesothelial-mesenchymal transition, inflammation and angiogenesis","volume":"13","author":"Masola V","year":"2021","unstructured":"Masola V, Bonomini M, Onisto M, Ferraro PM, Arduini A, Gambaro G. Biological effects of XyloCore, a glucose sparing PD solution, on mesothelial cells: focus on mesothelial-mesenchymal transition, inflammation and angiogenesis. Nutrients. 2021, 13:2282. 10.3390\/nu13072282","journal-title":"Nutrients"},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2018.08.031","article-title":"A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to\u00a0assess impact on biomarkers of peritoneal\u00a0health","volume":"94","author":"Vychytil A","year":"2018","unstructured":"Vychytil A, Herzog R, Probst P, et al.. A randomized controlled trial of alanyl-glutamine supplementation in peritoneal dialysis fluid to\u00a0assess impact on biomarkers of peritoneal\u00a0health. Kidney Int. 2018, 94:1227-1237. 10.1016\/j.kint.2018.08.031","journal-title":"Kidney Int"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.3390\/life15020279","article-title":"Current progress in peritoneal dialysis: a narrative review of progress in peritoneal dialysis fluid","volume":"15","author":"Hashimoto K","year":"2025","unstructured":"Hashimoto K, Kamijo Y. Current progress in peritoneal dialysis: a narrative review of progress in peritoneal dialysis fluid. Life (Basel). 2025, 15:279. 10.3390\/life15020279","journal-title":"Life (Basel)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/462802-management-of-hypertension-in-patients-undergoing-peritoneal-dialysis-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T12:17:45Z","timestamp":1773490665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/462802-management-of-hypertension-in-patients-undergoing-peritoneal-dialysis-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,14]]},"references-count":126,"URL":"https:\/\/doi.org\/10.7759\/cureus.105215","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,14]]}}}